16.11.2012 German Cancer Research Centre

Science and industry join forces to optimize cancer treatment

Roche has concluded its first collaborative agreement on personalized healthcare with the National Center for Tumor Diseases (NCT), represented by its supporting institutions, the German Cancer Research Center (DKFZ) and Heidelberg University Hospital. The aim is to strengthen cooperation between all participating partners in the early stages of oncology research and development projects so that patients reap benefit from innovations sooner. Two projects are already underway. Joint press release of German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Roche, Heidelberg University Hospital (Universitätsklinikum Heidelberg) and National Center for Tumor Diseases (Nationales Centrum für Tumorerkrankungen, NCT)

Link

more Information